« Back
Home /
Losmapimod

Losmapimod

Manufacturer	MedChem Express
Category	Oncology Neuroscience Neural Signaling Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	50 mg
Item no.	HY-10402-50mg
Targets	p38 MAPK; Autophagy
CASRN	585543-15-3
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Losmapimod (GSK-AHAB) is a selective, potent, and orally active p38 MAPK inhibitor with pKis of 8.1 and 7.6 for p38α and p38β, respectively[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	383.46
Clinical_Information	Phase 3
Manufacturers Research_Area	Inflammation/Immunology; Cancer
Solubility	DMSO : 27.5 mg/mL (ultrasonic)\|Ethanol : 33.33 mg/mL (ultrasonic)
Manufacturers Target	Autophagy; p38 MAPK
Pathway	Autophagy; MAPK/ERK Pathway
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-10402-50mg-safety-datasheet.pdf